Product Information
FOCALIN 5 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $0.9206 per EA under NDC 00078038105. Its NADAC has been published 654 times since Nov 28, 2013.
FDA first approved this application on Nov 13, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078038105
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021278FDA Approved
11/13/2001
TE Code
AB
On Market Since
11/30/2001
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN 5 MG TABLET has been published 654 times since Nov 28, 2013, and over the history we have for it it has risen 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9206 per EA |
|---|---|
| All-time high | $0.9265 (Apr 16, 2025) |
| All-time low | $0.8628 (Apr 18, 2018) |
| 52-week high | $0.9249 |
| 52-week low | $0.9206 |
| Median price | $0.8720 |
| Average price | $0.8878 |
| Largest weekly change | +5.0% (Aug 3, 2022) |
| Weeks tracked | 654 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
0.0%
3M
-0.3%
6M
-0.2%
1Y
-0.5%
3Y
-0.5%
5Y
+6.3%
All
+2.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FOCALIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN 5 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $0.9206 per EA (NDC 00078038105), effective Jul 29, 2026.
How has the price of FOCALIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FOCALIN 5 MG TABLET has risen 2.0%. It has been tracked across 654 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FOCALIN 5 MG TABLET?
Since Nov 28, 2013, the NADAC for FOCALIN 5 MG TABLET has ranged from a low of $0.8628 (Apr 18, 2018) to a high of $0.9265 (Apr 16, 2025), with a median of $0.8720 per EA.
Are there cheaper alternatives to FOCALIN 5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE 5 MG TAB, is $0.2728 per EA — about 70% below FOCALIN 5 MG TABLET.
Who manufactures FOCALIN 5 MG TABLET?
FOCALIN 5 MG TABLET (NDC 00078038105) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.